...
首页> 外文期刊>Transplantation Proceedings >Kidney Transplantation With Organs From Donors After Circulatory Death Type 3: A Prospective Multicentric Spanish Study (GEODAS 3)
【24h】

Kidney Transplantation With Organs From Donors After Circulatory Death Type 3: A Prospective Multicentric Spanish Study (GEODAS 3)

机译:循环死亡后供体器官移植肾的肾脏类型3:一项前瞻性多中心西班牙研究(GEODAS 3)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To increase the number of kidney donors, new strategies are needed such as living donor programs, expanded criteria donors, or donors after circulatory death (DCD) kidney transplantation programs. The GEODAS group has started an observational, prospective, multicenter clinical study, collecting data from all DCD type-3 kidney transplantations performed in seven Spanish hospitals from January 2012 to January 2014. The preliminary results have shown a delayed graft function of 40.4% and graft survival of 93.7% with a nadir creatinine of 1.3 mg/dL. From all 33 potential donors included in the study, 32 were effective and 63 kidney grafts were transplanted with a utilization rate of 98.5%. Creatinine evolution (median [range]) was in the first month: 2.1 [0.6-5.6]; third month: 1.6 [0.8, 4.2]; first year: 1.6 [0.9-2.2]. These results are similar to kidney transplantation from donors after brain death as shown in the literature, especially in the graft and recipient survival rates. In addition, the controlled programs are easier and less expensive than uncontrolled DCD programs with a higher rate of graft use.
机译:为了增加肾脏供体的数量,需要新的策略,例如活体供体计划,扩大标准供体或循环死亡(DCD)肾移植后供体。 GEODAS小组已开始一项观察性,前瞻性,多中心临床研究,收集了2012年1月至2014年1月在西班牙七家医院进行的所有DCD 3型肾脏移植手术的数据。初步结果显示,移植物功能和移植物的延迟性为40.4%最低肌酐为1.3 mg / dL时生存率为93.7%。在研究中包括的所有33个潜在供体中,有32个有效供体,移植了63个肾移植物,利用率为98.5%。肌酐的演变(中位数[范围])在第一个月:2.1 [0.6-5.6];第三个月:1.6 [0.8,4.2];第一年:1.6 [0.9-2.2]。这些结果类似于文献报道的脑死亡后从供体进行肾脏移植,尤其是在移植物和受体存活率方面。此外,与移植率较高的非受控DCD程序相比,受控程序更容易且成本更低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号